Oncoclínicas do Brasil Serviços Médicos Toekomstige groei
Future criteriumcontroles 4/6
Oncoclínicas do Brasil Serviços Médicos zal naar verwachting groeien in winst en omzet met respectievelijk 47.6% en 11.7% per jaar. De winst per aandeel zal naar verwachting groeien met 48.2% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 9.1% zijn.
Belangrijke informatie
47.6%
Groei van de winst
48.2%
Groei van de winst per aandeel
| Healthcare winstgroei | 26.9% |
| Inkomstengroei | 11.7% |
| Toekomstig rendement op eigen vermogen | 9.1% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 13 Nov 2024 |
Recente toekomstige groei-updates
Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 17
Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results
Aug 15Recent updates
Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Problems Go Beyond Weak Profit
Nov 20Oncoclínicas do Brasil Serviços Médicos S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
Nov 17With A 25% Price Drop For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) You'll Still Get What You Pay For
Sep 27Here's What Analysts Are Forecasting For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) After Its Second-Quarter Results
Aug 15Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Takes On Some Risk With Its Use Of Debt
Aug 13Earnings Tell The Story For Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) As Its Stock Soars 27%
Jul 16Is Now An Opportune Moment To Examine Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)?
Jul 03Investors Appear Satisfied With Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Prospects As Shares Rocket 25%
Jun 01Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Is Still Matching Investor Opinion Despite 27% Slump
Apr 17Oncoclínicas do Brasil Serviços Médicos' (BVMF:ONCO3) Earnings Are Weaker Than They Seem
Apr 03Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) Has A Somewhat Strained Balance Sheet
Mar 11What Does Oncoclínicas do Brasil Serviços Médicos S.A.'s (BVMF:ONCO3) Share Price Indicate?
Feb 17It's A Story Of Risk Vs Reward With Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Dec 08Why Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Could Be Worth Watching
Nov 06Is Now The Time To Put Oncoclínicas do Brasil Serviços Médicos (BVMF:ONCO3) On Your Watchlist?
Sep 11Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3) Just Reported Earnings, And Analysts Cut Their Target Price
Apr 03Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 8,233 | 513 | 359 | N/A | 8 |
| 12/31/2025 | 7,358 | 392 | 291 | N/A | 10 |
| 12/31/2024 | 6,447 | 216 | -553 | N/A | 8 |
| 9/30/2024 | 6,095 | 72 | -663 | -422 | N/A |
| 6/30/2024 | 5,862 | 193 | -614 | -310 | N/A |
| 3/31/2024 | 5,654 | 211 | -256 | 62 | N/A |
| 12/31/2023 | 5,489 | 224 | -363 | -52 | N/A |
| 9/30/2023 | 5,271 | 219 | -29 | 285 | N/A |
| 6/30/2023 | 5,033 | 145 | -249 | 78 | N/A |
| 3/31/2023 | 4,574 | 91 | -642 | -346 | N/A |
| 12/31/2022 | 4,088 | 46 | -572 | -272 | N/A |
| 9/30/2022 | 3,640 | -10 | -740 | -378 | N/A |
| 6/30/2022 | 3,155 | 105 | -593 | -324 | N/A |
| 3/31/2022 | 2,895 | -67 | -415 | -185 | N/A |
| 12/31/2021 | 2,702 | -47 | -211 | -9 | N/A |
| 9/30/2021 | 2,509 | -203 | -138 | 27 | N/A |
| 6/30/2021 | 2,354 | -334 | -128 | 9 | N/A |
| 3/31/2021 | 2,182 | -145 | -17 | 154 | N/A |
| 12/31/2020 | 2,035 | -158 | -19 | 186 | N/A |
| 12/31/2019 | 1,690 | -20 | -93 | 97 | N/A |
| 12/31/2018 | 1,051 | -17 | -296 | -18 | N/A |
| 12/31/2017 | 792 | 3 | N/A | 135 | N/A |
| 12/31/2016 | 595 | -25 | N/A | -21 | N/A |
| 12/31/2015 | 458 | -25 | N/A | -3 | N/A |
| 12/31/2014 | 359 | -22 | N/A | 9 | N/A |
| 12/31/2013 | 269 | 21 | N/A | 7 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei ONCO3 ( 47.6% per jaar) ligt boven de spaarquote ( 10.4% ).
Winst versus markt: De winst van ONCO3 ( 47.6% per jaar) zal naar verwachting sneller groeien dan de BR markt ( 12.6% per jaar).
Hoge groeiwinsten: De winst van ONCO3 zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van ONCO3 ( 11.7% per jaar) zal naar verwachting sneller groeien dan de markt BR ( 7.4% per jaar).
Hoge groei-inkomsten: De omzet van ONCO3 ( 11.7% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen ONCO3 zal naar verwachting over 3 jaar laag zijn ( 9.1 %).